Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

LON/HIK stock hub

LON/HIK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/HIKis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3B
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/HIK
In the news

Latest news · LON/HIK

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.6
P25 12.9P50 16.9P75 23.5
Trailing P/E10.5
P25 15.9P50 22.9P75 35.8
ROE16.5
P25 -54.2P50 2.1P75 13.7
ROIC12.8
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/HIK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
248
Groups with data
11
Currency
USD
Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United Kingdom
Country code
UK
Employees
9,400
Employees Change
-100%
Employees Change Percent
-1.05
Enterprise value
GBX 4.1B
Exchange
London Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
GB00B0LCW083
Last refreshed
2026-05-10
Market cap
GBX 3B
Price
GBX 1,418
Price currency
GBX
Rev Per Employee
264,713.51x
Sector
Healthcare
Sic
2834
Symbol
lon/HIK
Website
https://www.hikma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

15
MetricValue
Earnings Yield
9.81%
EV Earnings
13.61x
EV/EBIT
8.45x
EV/EBITDA
6.42x
EV/FCF
22.9x
EV/Sales
1.63x
FCF yield
5.83%
Forward P/E
8.58x
P/B ratio
1.57x
P/E ratio
10.54x
P/S ratio
1.22x
PE Ratio10 Y
19.18x
PE Ratio3 Y
14.84x
PE Ratio5 Y
19.03x
PEG ratio
1.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
19.35%
EBITDA Margin
25.14%
FCF margin
7.14%
Gross margin
43.51%
Gross Profit
GBX 1.1B
Gross Profit Growth
5.27%
Gross Profit Growth Q
10.41%
Gross Profit Growth3 Y
0.21%
Gross Profit Growth5 Y
1.43%
Net Income
GBX 298.7M
Net Income Growth
11.98%
Net Income Growth Q
23.31%
Net Income Growth Quarters
5%
Net Income Growth Years
3%
Net Income Growth3 Y
12.15%
Net Income Growth5 Y
22.45%
Pretax Margin
15.5%
Profit Margin
12%
Profit Per Employee
GBX 31,775
Profitable Years
8
ROA
7.5
Roa5y
7.83
ROCE
15.36
ROE
16.52
Roe5y
13.56
ROIC
12.81
Roic5y
14.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

30
MetricValue
Cagr10y
-2.09%
Cagr15y
5.52%
Cagr1y
-26.15%
Cagr20y
7.38%
Cagr3y
-5.75%
Cagr5y
-6.9%
Div CAGR10
10.39%
Div CAGR3
7.8%
Div CAGR5
10.71%
EPS Growth
12.42
EPS Growth Q
23.5
EPS Growth Quarters
5
EPS Growth Years
3
EPS Growth3 Y
12.47
EPS Growth5 Y
22.36
FCF Growth
-40.1%
FCF Growth Q
-45.93%
FCF Growth3 Y
-17.78%
FCF Growth5 Y
-10.83%
OCF Growth
-22.7%
OCF Growth Q
-24.86%
OCF Growth10 Y
-0.62%
OCF Growth3 Y
-9.28%
OCF Growth5 Y
-5.65%
Revenue Growth
7.1x
Revenue Growth Q
8.54x
Revenue Growth Quarters
6x
Revenue Growth Years
3x
Revenue Growth3 Y
3.54x
Revenue Growth5 Y
4.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
GBX 0.62
Assets
GBX 4.2B
Cash
GBX 180.5M
Current Assets
GBX 1.9B
Current Liabilities
GBX 1.1B
Debt
GBX 1.2B
Debt EBITDA
GBX 1.88
Debt Equity
GBX 0.62
Debt FCF
GBX 6.71
Equity
GBX 1.9B
Interest Coverage
7.62
Liabilities
GBX 2.3B
Long Term Assets
GBX 2.3B
Long Term Liabilities
GBX 1.2B
Net Cash
GBX -1B
Net Cash By Market Cap
GBX -33.2
Net Debt EBITDA
GBX 1.62
Net Debt Equity
GBX 0.52
Net Debt FCF
GBX 5.69
Tangible Book Value
GBX 1.1B
Tangible Book Value Per Share
GBX 4.8
WACC
6.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.82
Inventory Turnover
1.81
Net Working Capital
GBX 788.3M
Quick ratio
0.91
Working Capital
GBX 884.2M
Working Capital Turnover
GBX 3.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
0.36%
Dividend Growth
0.99%
Dividend Growth Years
4%
Dividend per share
GBX 0.62
Dividend Years
21
Dividend Yield
4.35%
Ex Div Date
2026-03-19
Last Dividend
GBX 0.36
Payout Frequency
Semi-Annual
Payout Ratio
46.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-19.08%
1Y total return
-26.14%
200-day SMA
1,581
3Y total return
-16.29%
50-day SMA
1,313.9
50-day SMA vs 200-day SMA
50under200
5Y total return
-30.04%
All Time High
2,768
All Time High Change
-48.79%
All Time High Date
2020-11-05
All Time Low
225
All Time Low Change
530%
All Time Low Date
2008-11-24
ATR
38.07
Beta
0.64
Beta1y
0.46
Beta2y
0.38
Ch YTD
-8.55
High
1,425
High52
2,164
High52 Date
2025-05-29
High52ch
-34.5%
Low
1,402.5
Low52
1,187
Low52 Date
2026-03-09
Low52ch
19.42%
Ma50ch
7.88%
Price vs 200-day SMA
-10.34%
RSI
60.68
RSI Monthly
38.84
RSI Weekly
44.56
Sharpe ratio
-0.85x
Sortino ratio
-0.88
Total Return
4.71%
Tr YTD
-5.91
Tr15y
124.03%
Tr1m
10.27%
Tr1w
0.67%
Tr3m
-5.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
GBX 481.5M
Operating Income Growth
11.34
Operating Income Growth Q
29.25
Operating Income Growth3 Y
-3.36
Operating Income Growth5 Y
4.87
Operating margin
19.35

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
147,720,058%
Net Borrowing
212,719,060
Shares Insiders
2.6%
Shares Institutions
61.95%
Shares Out
214,854,462
Shares Qo Q
0.23%
Shares Yo Y
-0.36%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

66
MetricValue
Adjusted FCF
GBX 160.5M
Average Volume
786,860.45x
Bv Per Share
8.75
CAPEX
GBX -146.4M
Ch10y
-35.71
Ch15y
77.97
Ch1m
10.27
Ch1w
0.67
Ch1y
-29.27
Ch20y
230
Ch3m
-7.95
Ch3y
-24.36
Ch5y
-39.68
Ch6m
-10.4
Change
0.5%
Change From Open
0.5
Close
1,410.5
Days Gap
0
Depreciation Amortization
142,301,716
Dollar Volume
1,133,943,300
Earnings Date
2026-08-06
EBIT
GBX 481.5M
EBITDA
GBX 625.6M
EPS
GBX 1.34
F Score
7
FCF
GBX 177.6M
FCF EV Yield
4.37x
FCF Per Share
GBX 0.83
Financing CF
-18,575,000
Fiscal Year End
December
Founded
1,978
Goodwill
288,271,002
Graham Number
1678.943
Graham Upside
18.44
Income Tax
GBX 83.2M
Investing CF
-288,284,000
Is Primary Listing
1
Last Earnings Date
2026-02-26
Last Report Date
2025-12-31
Lynch Fair Value
GBX 3,122
Lynch Upside
120.2
Ma150
1,516.9
Ma150ch
-6.55%
Ma20
1,376.5
Ma20ch
2.98%
Net CF
21,547,000
Next Earnings Date
2026-08-06
Open
1,410.5
P FCF Ratio
17.15
P OCF Ratio
9.4
Payment Date
2026-04-30
Position In Range
66.67
Ppne
1,062,128,272
Price Date
2026-05-08
Price EBITDA
GBX 4.87
Ptbv Ratio
2.88
Relative Volume
1.08x
Revenue
2,488,307,000x
SBC By Revenue
0.69x
Share Based Comp
17,089,000
Tax By Revenue
3.34x
Tax Rate
21.58%
Tr20y
315.46%
Tr6m
-7.81%
Volume
799,960
Z Score
2.94
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

LON/HIK dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+4.3%
$0.62 annual per share
Payout ratio
+46.0%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+10.7%
4 consecutive years of growth
Total shareholder yield
+4.7%
Next ex-dividend date: 2026-03-19
Performance

LON/HIK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-26.1%
S&P 500 1Y: n/a
3Y total return
-16.3%
S&P 500 3Y: n/a
5Y total return
-30.0%
S&P 500 5Y: n/a
10Y total return
-19.1%
S&P 500 10Y: n/a
Ownership

Who owns LON/HIK?

Insider, institutional, and short-interest positioning.

Institutional ownership
+62.0%
Share of float held by funds and institutions
Insider ownership
+2.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.4%
Negative means the company is buying back shares.
Technical

LON/HIK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
60.7
Neutral momentum band
Price vs 200-day MA
-10.3%
50/200-day relationship not available
Beta (5Y)
0.64
Less volatile than the market
Sharpe ratio
-0.85
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/HIK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/HIK stock rating?

lon/HIK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/HIK analysis?

The full report lives at /stocks/lon/HIK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/HIK?

The latest report frames lon/HIK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/HIK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

lon/HIK stock profile: metrics, valuation and analysis | Agente AI del Mercato Azionario